Gland Pharma Limited has informed the Exchange about Schedule of meet
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gland Pharma has informed the stock exchanges about an upcoming one-on-one meeting with HDFC Mutual Fund scheduled for May 23, 2025. The disclosure was made under SEBI's Listing Obligations and Disclosure Requirements (Regulation 30) as a standard compliance filing. The filing shares only the schedule of the company's interaction with institutional investors and does not contain any new financial or business information. Gland Pharma has noted that the schedule is subject to change due to last-minute exigencies from either party. The meeting was signed off by Sampath Kumar Pallerlamudi, the Company Secretary and Compliance Officer.
This is a routine investor engagement announcement with no direct material impact on the stock price. A one-on-one meeting with a large fund house like HDFC Mutual Fund suggests continued institutional interest in the stock, which is mildly positive for sentiment.